OneTouch

What OneTouch does

OneTouch is a long-standing blood glucose monitoring brand owned and operated by LifeScan Enterprises LLC, selling a connected ecosystem of consumer diabetes devices and software to people living with diabetes and their care teams. The product line comprises three meters (Verio Reflect, Verio Flex, and Ultra 2), proprietary matching test strips (Verio and Ultra), the Delica Plus lancing device, and the OneTouch Reveal mobile and web application that syncs data via Bluetooth. The Reveal app adds a digital logbook, trend visualization, hypo/hyper anomaly detection, Blood Sugar Mentor personalized coaching, and one-tap sharing with healthcare providers and family members, with integrations to Apple HealthKit and Google Health Connect extending data into consumer health platforms.

The business operates a classic razor-and-blade consumable model: meters are effectively distributed free (one coupon per person every 12 months) to seed the installed base, while recurring revenue comes from Verio and Ultra test strips sold through pharmacy chains (Shoppers Drug Mart, Pharmaprix, Rexall, Loblaws, Safeway, Jean Coutu, London Drugs, Pharmasave, Walmart, Uniprix) and through healthcare providers. The Reveal app is freemium and generates no direct revenue but underpins engagement, retention, and data share. Go-to-market combines direct-to-consumer acquisition (free meter offers, content marketing, social, email) with professional recommendation channels (endocrinologists, diabetes educators, pharmacists), and the company projects a "world leader" position with 20+ million global users and 40+ years of category experience. Compliance posture spans HIPAA, PIPEDA, and CCPA, and operations extend across North America, Europe, APAC, Latin America, the Middle East, Africa, and South Asia via the LifeScan corporate family (LifeScan Canada ULC, LifeScan U.S. LLC).

Revenue figures are not publicly disclosed. The brand is profitable-looking but mature, operating in a category structurally challenged by continuous glucose monitors; differentiation rests on consumer brand trust (BrandSpark Most Trusted in Canada 2021-2025), a wide pharmacy distribution moat, and a layered meter-strip-lancet-app ecosystem that creates consumable lock-in.

Name

OneTouch

Legal name

OneTouch®

Website

https://onetouch.ca

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

1–10 employees

Short description

OneTouch, a brand of LifeScan Enterprises LLC, sells Bluetooth-enabled blood glucose meters, proprietary test strips, a lancing device, and the OneTouch Reveal mobile app to people with diabetes, generating recurring revenue from consumable strips distributed through major Canadian and global pharmacy chains.

Ownership category

akta.pro rank

Product category

Blood Glucose Monitoring

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Blood Glucose Monitoring (BGM) Meters & Test Strips (HLAHAHAG)

akta.pro secondary industries

Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers) (CRACAQAE), Diabetes Care Device Accessories & Adhesives (Sensors/Pump Supplies) (HLAHAHAL)

Keywords

• Blood glucose monitoring
• Diabetes management
• Glucose meters
• Diabetes test strips
• Lancing devices

Headquarters

HQ city

Burnaby

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Technology or R&D, Operations, Personnel, Infrastructure

Revenue model

1. Blood Glucose Meters: Sale of OneTouch Verio Reflect, Verio Flex, and Ultra 2 blood glucose meters. The company offers free meters to eligible customers as a customer acquisition strategy, with the primary revenue opportunity in consumables.
2. Test Strips: Recurring revenue from OneTouch Verio and Ultra test strip consumables. Test strips are required for each blood glucose test and represent the primary ongoing revenue stream. Sold through pharmacies and healthcare providers.
3. Lancing Devices and Accessories: Sale of Delica Plus lancing devices and accessories. These complementary products support the core blood glucose monitoring ecosystem.
4. OneTouch Reveal App: Free mobile and web application that drives customer engagement and loyalty to the OneTouch ecosystem. The app does not generate direct revenue but supports hardware and consumable sales by enhancing user experience and retention.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

OneTouch sells blood glucose meters (OneTouch Verio Reflect, Verio Flex, Ultra 2), compatible test strips, the Delica Plus lancing device, and the OneTouch Reveal mobile and web application for people with diabetes. The hardware ecosystem is paired with Bluetooth-enabled data sync to the OneTouch Reveal app, which provides color-coded result interpretation, hypo/hyper trend detection, and data sharing with healthcare providers and family members.

Product overview

OneTouch offers a comprehensive diabetes management ecosystem consisting of three blood glucose meters (OneTouch Verio Reflect®, OneTouch Verio Flex®, and OneTouch Ultra®2), companion test strips (OneTouch Verio® and OneTouch Ultra®), a lancing device (OneTouch® Delica® Plus), and the OneTouch Reveal® mobile and web application. The meters connect via Bluetooth® to the OneTouch Reveal® app, which organizes blood glucose data with color coding, detects recurring high/low blood sugar trends, and enables users to share their results with healthcare providers and caregivers.

Differentiator

Problem solved

Functional benefit

Brands

• OneTouch Verio Reflect®: Blood glucose meter with smartphone connectivity and Blood Sugar Mentor feature providing personalized insights, guidance, and encouragement.
• OneTouch Verio Flex®
• OneTouch Ultra®2
• OneTouch Reveal®
• OneTouch Delica® Plus
• OneTouch Verio® test strips
• OneTouch Ultra® test strips

Products and services

• OneTouch Verio Reflect Blood glucose meter with Bluetooth connectivity featuring the Blood Sugar Mentor (Coach de Glycémie) technology that provides personalized advice, insights, and encouragement to help manage diabetes. Designed for people with Type 1, Type 2, or gestational diabetes.
• OneTouch Verio Flex Blood glucose meter with smartphone connectivity via Bluetooth that syncs results to the OneTouch Reveal app, featuring ColourSure technology to organize readings with color-coded indicators.
• OneTouch Ultra 2 Blood glucose meter that displays results to help users understand and respond to their blood sugar levels.

Quantifiable outcome

• Voted most trusted Glucose Monitor brand by Canadian shoppers for 2021-2025

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability3 records

Feature7 records

Partnerships

Six partnerships are on record, tiered core and supporting.

• Apple HealthcoreTechnology or IntegrationIntegration with Apple HealthKit allows iOS users to share their OneTouch Reveal information with the Apple Health app, providing a comprehensive view of their overall health.
• Google Health ConnectcoreTechnology or IntegrationIntegration with Google Health Connect enables users to sync their OneTouch Reveal blood glucose data with the Google Health Connect platform. Usage adheres to Health Connect Permissions policy including Limited Use requirements.
• Bluetooth SIGcoreTechnology or IntegrationThe Bluetooth word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. OneTouch Verio Reflect and Verio Flex meters use Bluetooth wireless technology for data sync with mobile apps.
• Amazon Web ServicessupportingTechnology or IntegrationPersonal information is stored in an encrypted database managed by Amazon Web Services. Supports the cloud infrastructure for OneTouch Reveal app and web services.
• RackspacesupportingTechnology or IntegrationRackspace provides 24/7 cloud security management as a third-party trusted partner, ensuring the security of OneTouch Reveal data storage and processing.
• Pharmacies and Healthcare ProviderscoreChannel Partner/ Reseller/ DistributorProducts available through pharmacies including Shoppers Drug Mart, Pharmaprix, Rexall, Loblaws, and others. Healthcare professionals recommend OneTouch products to patients for diabetes management.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Roche Diabetes Care (Accu-Chek): Roche's Accu-Chek is the global BGM market leader with a comparable product portfolio of meters, strips, lancing devices, and a connected app. Direct head-to-head competitor to OneTouch across both consumer pharmacy channels and healthcare provider recommendations.
• Ascensia Diabetes Care (Contour): Ascensia's Contour portfolio (Contour Next, Contour Plus) competes directly with OneTouch Verio in meters, strips, and connected apps including Contour Diabetes App. Same razor-and-blade model, same pharmacy channels, same patient segments.
• Trividia Health (True Metrix): Trividia's True Metrix and TRUEtrack meters compete with OneTouch Ultra and Verio in retail pharmacy and mail-order BGM channels. A focused, smaller-scale BGM peer with similar consumable-driven economics.
• i-SENS (CareSens): Korean-based i-SENS manufactures CareSens BGM meters and strips sold globally including in North America. A direct product and channel peer with comparable Bluetooth-connected meters and a freemium app ecosystem.
• ARKRAY (GLUCOCARD): Japanese diagnostics company ARKRAY produces GLUCOCARD and Aria BGM systems and strips. Competes with OneTouch in both consumer and clinical BGM segments globally, with similar technology profiles and pharmacy distribution.

Broad incumbents

• Abbott Diabetes Care (FreeStyle): Abbott sells FreeStyle Libre CGM systems alongside traditional FreeStyle BGM meters and strips. Overlaps with OneTouch in BGM strips and increasingly encroaches on the same patients via CGM, making Abbott the most strategically threatening peer.
• Medtronic Diabetes: Medtronic offers the Guardian CGM system integrated with its insulin pumps (MiniMed 780G), serving the same insulin-dependent diabetes patients that consume the most test strips. A broader incumbent competing for the same HCP prescriptions and patient relationships.

Emerging players

• Dexcom: Dexcom (G6, G7) is the leading standalone CGM company and the most disruptive force to traditional BGM. As CGM expands from Type 1 into Type 2 diabetes, Dexcom directly substitutes for OneTouch's strip-based testing in the highest-value patient segments.
• Ypsomed (mylife): Swiss-based Ypsomed offers the mylife Diabetescare portfolio including BGM systems and insulin pumps. Overlaps with OneTouch in the BGM category while extending into adjacent diabetes delivery devices.
• Senseonics (Eversense): Senseonics markets the Eversense implantable CGM, an emerging alternative to traditional CGM and finger-prick BGM. Represents the long-term technological trajectory that could further erode BGM strip demand that underpins OneTouch's recurring revenue.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/OneTouchCA
• Facebookfacebook.com/OneTouchCanada
• Xx.com/OneTouch
• LinkedInlinkedin.com/company/lifescan-canada-ltd-

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OneTouch